175 related articles for article (PubMed ID: 15996722)
1. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.
Lai HC; Lin WY; Lin YW; Chang CC; Yu MH; Chen CC; Chu TY
Gynecol Oncol; 2005 Oct; 99(1):113-8. PubMed ID: 15996722
[TBL] [Abstract][Full Text] [Related]
2. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D
J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis.
Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY
Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036
[TBL] [Abstract][Full Text] [Related]
4. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
[TBL] [Abstract][Full Text] [Related]
7. The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.
Xu Y; Deng Q; He B; Pan Y; Li R; Gao T; Sun H; Song G; Wang S; Cho WC
Tumour Biol; 2014 Sep; 35(9):9147-61. PubMed ID: 24916571
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
9. [Association between Fas/Fas L genes promoter polymorphisms and pathogenic risk of cervical cancer].
Li H; Guo HY; Sun T; Zhou YF; Lin DX; Zhang WH; Qiao J
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):38-41. PubMed ID: 19538867
[TBL] [Abstract][Full Text] [Related]
10. Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus.
Moudi B; Salimi S; Farajian Mashhadi F; Sandoughi M; Zakeri Z
ScientificWorldJournal; 2013; 2013():176741. PubMed ID: 24348139
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
Shao P; Ding Q; Qin C; Wang M; Tang J; Zhu J; Chen J; Cao Q; Li J; Xu B; Zhang Z; Zhang W; Yin C
Prostate; 2011 Jul; 71(10):1122-30. PubMed ID: 21557277
[TBL] [Abstract][Full Text] [Related]
13. Relationship between polymorphisms in the FAS/FASL death receptor system and progression of low-grade precursor lesions infected with high-risk human papilloma virus.
Santaclara V; Torres-Moreno D; Bernal-Mañas CM; Isaac MA; Ortiz-Reina S; Conesa-Zamora P
Hum Immunol; 2021 Sep; 82(9):621-624. PubMed ID: 34127318
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
[TBL] [Abstract][Full Text] [Related]
15. Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis.
Ueda M; Hung YC; Terai Y; Yamaguchi H; Saito J; Nunobiki O; Noda S; Ueki M
Gynecol Oncol; 2005 Jul; 98(1):129-33. PubMed ID: 15894356
[TBL] [Abstract][Full Text] [Related]
16. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.
Park SH; Choi JE; Kim EJ; Jang JS; Lee WK; Cha SI; Kim CH; Kam S; Kim DS; Park RW; Kim YC; Han SB; Jung TH; Park JY
Lung Cancer; 2006 Dec; 54(3):303-8. PubMed ID: 17014925
[TBL] [Abstract][Full Text] [Related]
18. Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.
Wang GQ; Bao L; Zhao XX; Zhang J; Nan KJ
Tumour Biol; 2014 May; 35(5):4107-12. PubMed ID: 24375196
[TBL] [Abstract][Full Text] [Related]
19. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]